Familial hypercholesterolaemia trials in Switzerland

1 of 2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

  Where

  Basel

  Age

  18 years to 99 years

  People

  5,995

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07543731